FDA NDC Directory · JSON-LD · Markdown

AJOVY

NDC 51759-202 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namefremanezumab-vfrm
Labeler / ManufacturerTeva Pharmaceuticals USA, Inc.
Marketing categoryBiologic License Application · App BLA761089
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsFREMANEZUMAB (225 mg/1.5mL)
Marketing started20200329
Package count3

External sources

Source: openFDA. Public-domain (CC0).